Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clopidogrel Resistance”

58 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 58 results

Not applicableActive Not RecruitingNCT07597239
What this trial is testing

Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity Revascularization

Who this might be right for
ThrombosisArterial Occlusive DiseasesThromboelastography (TEG)+4 more
Massachusetts General Hospital 130
Not applicableLooking for participantsNCT05566301
What this trial is testing

Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)

Who this might be right for
Clopidogrel, Poor Metabolism ofCarotid Stenosis
IRCCS Policlinico S. Donato 1,140
Not applicableStudy completedNCT04990596
What this trial is testing

Mechanisms fo Clopidogrel Resistance in Older Adults (CEPAGE)

Who this might be right for
Drug Resistance
Rennes University Hospital 37
Not applicableStudy completedNCT00302913
What this trial is testing

Efficacy of Adjusted Clopidogrel Dose in Patients With Insufficient Platelet Inhibition

Who this might be right for
Coronary Artery DiseaseDrug Resistance
University Heart Center Freiburg - Bad Krozingen 120
Not applicableStudy completedNCT02624583
What this trial is testing

Effects of RF on Clopidogrel Resistance in Patients at High Cardiovascular Risk

Who this might be right for
Coronary Artery DiseaseDiabetes Mellitus
University of Monastir 98
Large-scale testing (Phase 3)Study completedNCT01155765
What this trial is testing

Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis

Who this might be right for
HemodialysisChronic Renal Failure
University of Patras 70
Not applicableNot Yet RecruitingNCT07028775
What this trial is testing

Biomarkers of Clopidogrel Resistance for Predicting Ischemic Recurrence After Cerebral Artery Stenting

Who this might be right for
Ischemic Stroke
Nanjing First Hospital, Nanjing Medical University 839
Not applicableStudy completedNCT01212302
What this trial is testing

Optimizing Aspirin and Clopidogrel Therapy (BOchum CLopidogrel and Aspirin Plan)

Who this might be right for
Coronary Artery Disease
Ruhr University of Bochum 500
Large-scale testing (Phase 3)Study completedNCT01109784
What this trial is testing

Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI).

Who this might be right for
Coronary Artery Disease (CAD)Acute Coronary Syndrome (ACS)
University of Patras 70
Testing effectiveness (Phase 2)Study completedNCT01097343
What this trial is testing

Clopidogrel Pharmacogenomics Project

Who this might be right for
Disease Susceptibility
University of North Carolina, Chapel Hill 50
Large-scale testing (Phase 3)Study completedNCT00444132
What this trial is testing

Clopidogrel Reloading in Clopidogrel Resistant Patients With ACS

Who this might be right for
Clopidogrel Non-Responsiveness
Sheba Medical Center 50
Large-scale testing (Phase 3)Study completedNCT01511471
What this trial is testing

Ticagrelor in Clopidogrel Resistant Patients Undergoing Chronic Hemodialysis

Who this might be right for
Platelet Reactivity
University of Patras 20
Not applicableUnknownNCT04027712
What this trial is testing

Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD

Who this might be right for
DiabetesClopidogrel ResistanceAmyloid+1 more
University of Athens 120
Post-approval studies (Phase 4)Not Yet RecruitingNCT06759272
What this trial is testing

Impact of CYP2C19 Genotype-guided Approach in Antiplatelet Therapy on Platelet Reactivity Index Among Coronary Artery Disease (CAD) Patients

Who this might be right for
Coronary Arterial Disease (CAD)ACS (Acute Coronary Syndrome)SCAD
Nur Hafizah Annezah binti Utuh 120
Post-approval studies (Phase 4)Study completedNCT01463150
What this trial is testing

Prasugrel 5mg Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Aged ≥75 Years and/or Weighing <60 kg Post Percutaneous Coronary Intervention (PCI)

Who this might be right for
Platelet Reactivity
University of Patras 27
Not applicableNot Yet RecruitingNCT06753149
What this trial is testing

Evaluation of the Efficacy of Novel Biomarkers in Predicting Clopidogrel Resistance in Patients with Ischemic Stroke

Who this might be right for
Ischemic StrokeTIA (Transient Ischemic Attack)Clopidogrel Resistance
Nanjing First Hospital, Nanjing Medical University 800
Not applicableStudy completedNCT00742430
What this trial is testing

Resistance on Antithrombotic Drugs in Ischemic Heart Disease

Who this might be right for
Coronary Artery Disease
University of Zagreb 141
Not applicableUnknownNCT01925872
What this trial is testing

Optimal Regimen in Endovascular Therapy in Ischemic Cerebrovascular Disease Based on Clopidogrel Resistance

Who this might be right for
Ischemic Cerebrovascular Disease
Zhongrong Miao 2,000
Not applicableLooking for participantsNCT07613840
What this trial is testing

Personalizing Thromboprophylaxis for Patients With Peripheral Artery Disease

Who this might be right for
Peripheral Arterial Disease (PAD)AmputationThrombosis+4 more
Massachusetts General Hospital 484
Not applicableUnknownNCT00517478
What this trial is testing

Thromboelastography As A Tool for Possible Clopidogrel Resistance in The Patients Treated With Primary PCI for STEMI

Who this might be right for
Myocardial InfarctionCardiovascular Disease
Assaf-Harofeh Medical Center 50
Load More Results